Table 1.
Genetic analysis of csld4 and csld1 mutants
| Crosses (female×male) | With insertiona | Without insertionb | Ratio | TEFc | TEM |
| csld4-2/+×csld4-2/+ | 368 | 361 | 1.02 | NA | NA |
| csld4-3/+×csld4-3/+ | 516 | 529 | 0.98 | NA | NA |
| csld4-2/+×Ler | 1293 | 1314 | 0.98 | 100% | NA |
| csld4-3/+×Ler | 1085 | 1052 | 1.03 | 100% | NA |
| Ler×csld4-2/+ | 0 | 1793 | 0.00 | NA | 0 |
| Ler×csld4-3/+ | 0 | 1652 | 0.00 | NA | 0 |
| csld1-1/+×csld1-1/+ | 62 | 61 | 1.02 | NA | NA |
| csld1-1/+×Col | 84 | 102 | 0.82 | 82% | NA |
| Col×csld1-1/+ | 0 | 180 | 0.00 | NA | 0% |
| Col×csld1-1/+; gD1/gD1d | 55 | 40 | 1.38 | 100% | NA |
| Col×csld1-1/+; GFP-D1/GFP-D1 | 23 | 24 | 0.96 | 100% | NA |
| Col×csld1-1/+; GFP-D1/– | 11e | 21 | 0.52 | 52% | NA |
a
Kanamycin-resistant progeny in a csld4-2 or csld4-3 mutant background or progeny positive for the PCR analysis in the csld1-1 mutant background.
b
Kanamycin-sensitive progeny in a csld4-2 or csld4-3 mutant background or progeny negative for the PCR analysis in the csld1-1 mutant background.
c
TE, transmission efficiency; TE=(progeny with insertion/progeny without insertion)×100%; TEF and TEM, female and male transmission efficiency, respectively; NA, not applicable.
d
gD1 represents the CSLD1 genomic DNA construct. D1 represents CSLD1.
e
All of these lines are associated with the GFP-CSLD1 transgenic insertion.